Form 8-K - Current report:
SEC Accession No. 0001193125-21-244068
Filing Date
2021-08-12
Accepted
2021-08-12 10:29:09
Documents
51
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d202246d8k.htm   iXBRL 8-K 27630
2 EX-99.1 d202246dex991.htm EX-99.1 67526
3 EX-99.2 d202246dex992.htm EX-99.2 45933
7 GRAPHIC g202246ex99_2s10g1.jpg GRAPHIC 219376
8 GRAPHIC g202246ex99_2s11g1.jpg GRAPHIC 349801
9 GRAPHIC g202246ex99_2s12g1.jpg GRAPHIC 307467
10 GRAPHIC g202246ex99_2s13g1.jpg GRAPHIC 242800
11 GRAPHIC g202246ex99_2s14g1.jpg GRAPHIC 325729
12 GRAPHIC g202246ex99_2s15g1.jpg GRAPHIC 306798
13 GRAPHIC g202246ex99_2s16g1.jpg GRAPHIC 431199
14 GRAPHIC g202246ex99_2s17g1.jpg GRAPHIC 290750
15 GRAPHIC g202246ex99_2s18g1.jpg GRAPHIC 146466
16 GRAPHIC g202246ex99_2s19g1.jpg GRAPHIC 370399
17 GRAPHIC g202246ex99_2s1g1.jpg GRAPHIC 245485
18 GRAPHIC g202246ex99_2s20g1.jpg GRAPHIC 426770
19 GRAPHIC g202246ex99_2s21g1.jpg GRAPHIC 230385
20 GRAPHIC g202246ex99_2s22g1.jpg GRAPHIC 299484
21 GRAPHIC g202246ex99_2s23g1.jpg GRAPHIC 441677
22 GRAPHIC g202246ex99_2s24g1.jpg GRAPHIC 242703
23 GRAPHIC g202246ex99_2s25g1.jpg GRAPHIC 272982
24 GRAPHIC g202246ex99_2s26g1.jpg GRAPHIC 356797
25 GRAPHIC g202246ex99_2s27g1.jpg GRAPHIC 284679
26 GRAPHIC g202246ex99_2s28g1.jpg GRAPHIC 285127
27 GRAPHIC g202246ex99_2s29g1.jpg GRAPHIC 369997
28 GRAPHIC g202246ex99_2s2g1.jpg GRAPHIC 658343
29 GRAPHIC g202246ex99_2s30g1.jpg GRAPHIC 276307
30 GRAPHIC g202246ex99_2s31g1.jpg GRAPHIC 195862
31 GRAPHIC g202246ex99_2s32g1.jpg GRAPHIC 307277
32 GRAPHIC g202246ex99_2s33g1.jpg GRAPHIC 259994
33 GRAPHIC g202246ex99_2s34g1.jpg GRAPHIC 236103
34 GRAPHIC g202246ex99_2s35g1.jpg GRAPHIC 283427
35 GRAPHIC g202246ex99_2s36g1.jpg GRAPHIC 309723
36 GRAPHIC g202246ex99_2s3g1.jpg GRAPHIC 449829
37 GRAPHIC g202246ex99_2s4g1.jpg GRAPHIC 319022
38 GRAPHIC g202246ex99_2s5g1.jpg GRAPHIC 380663
39 GRAPHIC g202246ex99_2s6g1.jpg GRAPHIC 396488
40 GRAPHIC g202246ex99_2s7g1.jpg GRAPHIC 300328
41 GRAPHIC g202246ex99_2s8g1.jpg GRAPHIC 260919
42 GRAPHIC g202246ex99_2s9g1.jpg GRAPHIC 326738
43 GRAPHIC g202246g80i53.jpg GRAPHIC 4645
  Complete submission text file 0001193125-21-244068.txt   16012293

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lrmr-20210812.xsd EX-101.SCH 2894
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lrmr-20210812_lab.xml EX-101.LAB 18138
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lrmr-20210812_pre.xml EX-101.PRE 11409
44 EXTRACTED XBRL INSTANCE DOCUMENT d202246d8k_htm.xml XML 3366
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 211165906
SIC: 2834 Pharmaceutical Preparations